Alembic unveils 2 generics

Alembic is releasing two new generics.

The company is introducing Glycopyrrolate Injection, 0.2mg/ml and 0.4mg/2ml (0.2mg/ml) Single-Dose Vials and 1mg/5ml (0.2mg/ml) and 4mg/20ml (0.2mg/ml) multi-dose vials, which is the generic of Hikma’s Robinul.

Glycopyrrolate Injection is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the volume and free acidity of gastric secretions; and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.

[Read more: Alembic intros generic Perforomist]

Alembic also is presenting Fluorouracil Injection, 5g/100ml (50mg/ml), pharmacy bulk vial, which is the generic of Pharmacia and Upjohn’s Adrucil.  

Fluorouracil Injection is a nucleoside metabolic inhibitor indicated for the treatment of patients with adenocarcinoma of the colon and rectum, adenocarcinoma of the breast, gastric adenocarcinoma and pancreatic adenocarcinoma.